Global Targeted Radiotherapy Drug Supply, Demand and Key Producers, 2023-2029

November 2023 | 101 pages | ID: GEBE1624D07AEN
GlobalInfoResearch

Abstracts

The global Targeted Radiotherapy Drug market size is expected to reach $ 8868.3 million by 2029, rising at a market growth of 5.6% CAGR during the forecast period (2023-2029).

Targeted radiotherapy is a medical treatment designed to direct radioactive isotopes to specific types of tumor cells or tumor markers, allowing for precise tumor treatment. These drugs offer a promising treatment for some malignant tumors, especially those that are advanced or difficult to surgically remove. As technology develops, treatment effects, as well as patient survival and quality of life after treatment, can be better monitored and evaluated. The development trend of targeted radiotherapy drugs emphasizes precise treatment, personalized treatment and comprehensive treatment methods. This will hopefully provide more effective cancer treatments in the future and improve patient survival and quality of life.

This report studies the global Targeted Radiotherapy Drug demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Targeted Radiotherapy Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Radiotherapy Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Targeted Radiotherapy Drug total market, 2018-2029, (USD Million)

Global Targeted Radiotherapy Drug total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Targeted Radiotherapy Drug total market, key domestic companies and share, (USD Million)

Global Targeted Radiotherapy Drug revenue by player and market share 2018-2023, (USD Million)

Global Targeted Radiotherapy Drug total market by Type, CAGR, 2018-2029, (USD Million)

Global Targeted Radiotherapy Drug total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Targeted Radiotherapy Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bayer, Endocyte, Progenics Pharmaceuticals, Jubilant Radiopharma, Curium, Fermi Energia and Nucleus RadioPharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Radiotherapy Drug market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Targeted Radiotherapy Drug Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Targeted Radiotherapy Drug Market, Segmentation by Type

• Radioactive Iodine Therapeutic Drugs
• Radioactive Antibody Therapeutic Drugs
• Others

Global Targeted Radiotherapy Drug Market, Segmentation by Application

• General Hospital
• Specialty Hospital

Companies Profiled:

• Novartis
• Bayer
• Endocyte
• Progenics Pharmaceuticals
• Jubilant Radiopharma
• Curium
• Fermi Energia
• Nucleus RadioPharma

Key Questions Answered

1. How big is the global Targeted Radiotherapy Drug market?

2. What is the demand of the global Targeted Radiotherapy Drug market?

3. What is the year over year growth of the global Targeted Radiotherapy Drug market?

4. What is the total value of the global Targeted Radiotherapy Drug market?

5. Who are the major players in the global Targeted Radiotherapy Drug market?

Contents

1 SUPPLY SUMMARY

1.1 Targeted Radiotherapy Drug Introduction
1.2 World Targeted Radiotherapy Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Targeted Radiotherapy Drug Total Market by Region (by Headquarter Location)
  1.3.1 World Targeted Radiotherapy Drug Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Targeted Radiotherapy Drug Market Size (2018-2029)
  1.3.3 China Targeted Radiotherapy Drug Market Size (2018-2029)
  1.3.4 Europe Targeted Radiotherapy Drug Market Size (2018-2029)
  1.3.5 Japan Targeted Radiotherapy Drug Market Size (2018-2029)
  1.3.6 South Korea Targeted Radiotherapy Drug Market Size (2018-2029)
  1.3.7 ASEAN Targeted Radiotherapy Drug Market Size (2018-2029)
  1.3.8 India Targeted Radiotherapy Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Targeted Radiotherapy Drug Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Targeted Radiotherapy Drug Major Market Trends

2 DEMAND SUMMARY

2.1 World Targeted Radiotherapy Drug Consumption Value (2018-2029)
2.2 World Targeted Radiotherapy Drug Consumption Value by Region
  2.2.1 World Targeted Radiotherapy Drug Consumption Value by Region (2018-2023)
  2.2.2 World Targeted Radiotherapy Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Targeted Radiotherapy Drug Consumption Value (2018-2029)
2.4 China Targeted Radiotherapy Drug Consumption Value (2018-2029)
2.5 Europe Targeted Radiotherapy Drug Consumption Value (2018-2029)
2.6 Japan Targeted Radiotherapy Drug Consumption Value (2018-2029)
2.7 South Korea Targeted Radiotherapy Drug Consumption Value (2018-2029)
2.8 ASEAN Targeted Radiotherapy Drug Consumption Value (2018-2029)
2.9 India Targeted Radiotherapy Drug Consumption Value (2018-2029)

3 WORLD TARGETED RADIOTHERAPY DRUG COMPANIES COMPETITIVE ANALYSIS

3.1 World Targeted Radiotherapy Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Targeted Radiotherapy Drug Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Targeted Radiotherapy Drug in 2022
  3.2.3 Global Concentration Ratios (CR8) for Targeted Radiotherapy Drug in 2022
3.3 Targeted Radiotherapy Drug Company Evaluation Quadrant
3.4 Targeted Radiotherapy Drug Market: Overall Company Footprint Analysis
  3.4.1 Targeted Radiotherapy Drug Market: Region Footprint
  3.4.2 Targeted Radiotherapy Drug Market: Company Product Type Footprint
  3.4.3 Targeted Radiotherapy Drug Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Targeted Radiotherapy Drug Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Targeted Radiotherapy Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Targeted Radiotherapy Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Targeted Radiotherapy Drug Consumption Value Comparison
  4.2.1 United States VS China: Targeted Radiotherapy Drug Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Targeted Radiotherapy Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Targeted Radiotherapy Drug Companies and Market Share, 2018-2023
  4.3.1 United States Based Targeted Radiotherapy Drug Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Targeted Radiotherapy Drug Revenue, (2018-2023)
4.4 China Based Companies Targeted Radiotherapy Drug Revenue and Market Share, 2018-2023
  4.4.1 China Based Targeted Radiotherapy Drug Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Targeted Radiotherapy Drug Revenue, (2018-2023)
4.5 Rest of World Based Targeted Radiotherapy Drug Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Targeted Radiotherapy Drug Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Targeted Radiotherapy Drug Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Targeted Radiotherapy Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Radioactive Iodine Therapeutic Drugs
  5.2.2 Radioactive Antibody Therapeutic Drugs
  5.2.3 Others
5.3 Market Segment by Type
  5.3.1 World Targeted Radiotherapy Drug Market Size by Type (2018-2023)
  5.3.2 World Targeted Radiotherapy Drug Market Size by Type (2024-2029)
  5.3.3 World Targeted Radiotherapy Drug Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Targeted Radiotherapy Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 General Hospital
  6.2.2 Specialty Hospital
6.3 Market Segment by Application
  6.3.1 World Targeted Radiotherapy Drug Market Size by Application (2018-2023)
  6.3.2 World Targeted Radiotherapy Drug Market Size by Application (2024-2029)
  6.3.3 World Targeted Radiotherapy Drug Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Novartis
  7.1.1 Novartis Details
  7.1.2 Novartis Major Business
  7.1.3 Novartis Targeted Radiotherapy Drug Product and Services
  7.1.4 Novartis Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Novartis Recent Developments/Updates
  7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Bayer
  7.2.1 Bayer Details
  7.2.2 Bayer Major Business
  7.2.3 Bayer Targeted Radiotherapy Drug Product and Services
  7.2.4 Bayer Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Bayer Recent Developments/Updates
  7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Endocyte
  7.3.1 Endocyte Details
  7.3.2 Endocyte Major Business
  7.3.3 Endocyte Targeted Radiotherapy Drug Product and Services
  7.3.4 Endocyte Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Endocyte Recent Developments/Updates
  7.3.6 Endocyte Competitive Strengths & Weaknesses
7.4 Progenics Pharmaceuticals
  7.4.1 Progenics Pharmaceuticals Details
  7.4.2 Progenics Pharmaceuticals Major Business
  7.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Product and Services
  7.4.4 Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Progenics Pharmaceuticals Recent Developments/Updates
  7.4.6 Progenics Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Jubilant Radiopharma
  7.5.1 Jubilant Radiopharma Details
  7.5.2 Jubilant Radiopharma Major Business
  7.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Product and Services
  7.5.4 Jubilant Radiopharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Jubilant Radiopharma Recent Developments/Updates
  7.5.6 Jubilant Radiopharma Competitive Strengths & Weaknesses
7.6 Curium
  7.6.1 Curium Details
  7.6.2 Curium Major Business
  7.6.3 Curium Targeted Radiotherapy Drug Product and Services
  7.6.4 Curium Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Curium Recent Developments/Updates
  7.6.6 Curium Competitive Strengths & Weaknesses
7.7 Fermi Energia
  7.7.1 Fermi Energia Details
  7.7.2 Fermi Energia Major Business
  7.7.3 Fermi Energia Targeted Radiotherapy Drug Product and Services
  7.7.4 Fermi Energia Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Fermi Energia Recent Developments/Updates
  7.7.6 Fermi Energia Competitive Strengths & Weaknesses
7.8 Nucleus RadioPharma
  7.8.1 Nucleus RadioPharma Details
  7.8.2 Nucleus RadioPharma Major Business
  7.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Product and Services
  7.8.4 Nucleus RadioPharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Nucleus RadioPharma Recent Developments/Updates
  7.8.6 Nucleus RadioPharma Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Targeted Radiotherapy Drug Industry Chain
8.2 Targeted Radiotherapy Drug Upstream Analysis
8.3 Targeted Radiotherapy Drug Midstream Analysis
8.4 Targeted Radiotherapy Drug Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Targeted Radiotherapy Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Targeted Radiotherapy Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Targeted Radiotherapy Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Targeted Radiotherapy Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Targeted Radiotherapy Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Targeted Radiotherapy Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Targeted Radiotherapy Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Targeted Radiotherapy Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Targeted Radiotherapy Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Targeted Radiotherapy Drug Players in 2022
Table 12. World Targeted Radiotherapy Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Targeted Radiotherapy Drug Company Evaluation Quadrant
Table 14. Head Office of Key Targeted Radiotherapy Drug Player
Table 15. Targeted Radiotherapy Drug Market: Company Product Type Footprint
Table 16. Targeted Radiotherapy Drug Market: Company Product Application Footprint
Table 17. Targeted Radiotherapy Drug Mergers & Acquisitions Activity
Table 18. United States VS China Targeted Radiotherapy Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Targeted Radiotherapy Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Targeted Radiotherapy Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Targeted Radiotherapy Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Targeted Radiotherapy Drug Revenue Market Share (2018-2023)
Table 23. China Based Targeted Radiotherapy Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Targeted Radiotherapy Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Targeted Radiotherapy Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Targeted Radiotherapy Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Targeted Radiotherapy Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Targeted Radiotherapy Drug Revenue Market Share (2018-2023)
Table 29. World Targeted Radiotherapy Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Targeted Radiotherapy Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Targeted Radiotherapy Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Targeted Radiotherapy Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Targeted Radiotherapy Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Targeted Radiotherapy Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Novartis Basic Information, Area Served and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Targeted Radiotherapy Drug Product and Services
Table 38. Novartis Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Novartis Recent Developments/Updates
Table 40. Novartis Competitive Strengths & Weaknesses
Table 41. Bayer Basic Information, Area Served and Competitors
Table 42. Bayer Major Business
Table 43. Bayer Targeted Radiotherapy Drug Product and Services
Table 44. Bayer Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bayer Recent Developments/Updates
Table 46. Bayer Competitive Strengths & Weaknesses
Table 47. Endocyte Basic Information, Area Served and Competitors
Table 48. Endocyte Major Business
Table 49. Endocyte Targeted Radiotherapy Drug Product and Services
Table 50. Endocyte Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Endocyte Recent Developments/Updates
Table 52. Endocyte Competitive Strengths & Weaknesses
Table 53. Progenics Pharmaceuticals Basic Information, Area Served and Competitors
Table 54. Progenics Pharmaceuticals Major Business
Table 55. Progenics Pharmaceuticals Targeted Radiotherapy Drug Product and Services
Table 56. Progenics Pharmaceuticals Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Progenics Pharmaceuticals Recent Developments/Updates
Table 58. Progenics Pharmaceuticals Competitive Strengths & Weaknesses
Table 59. Jubilant Radiopharma Basic Information, Area Served and Competitors
Table 60. Jubilant Radiopharma Major Business
Table 61. Jubilant Radiopharma Targeted Radiotherapy Drug Product and Services
Table 62. Jubilant Radiopharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Jubilant Radiopharma Recent Developments/Updates
Table 64. Jubilant Radiopharma Competitive Strengths & Weaknesses
Table 65. Curium Basic Information, Area Served and Competitors
Table 66. Curium Major Business
Table 67. Curium Targeted Radiotherapy Drug Product and Services
Table 68. Curium Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Curium Recent Developments/Updates
Table 70. Curium Competitive Strengths & Weaknesses
Table 71. Fermi Energia Basic Information, Area Served and Competitors
Table 72. Fermi Energia Major Business
Table 73. Fermi Energia Targeted Radiotherapy Drug Product and Services
Table 74. Fermi Energia Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Fermi Energia Recent Developments/Updates
Table 76. Nucleus RadioPharma Basic Information, Area Served and Competitors
Table 77. Nucleus RadioPharma Major Business
Table 78. Nucleus RadioPharma Targeted Radiotherapy Drug Product and Services
Table 79. Nucleus RadioPharma Targeted Radiotherapy Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Targeted Radiotherapy Drug Upstream (Raw Materials)
Table 81. Targeted Radiotherapy Drug Typical Customers

LIST OF FIGURE

Figure 1. Targeted Radiotherapy Drug Picture
Figure 2. World Targeted Radiotherapy Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Targeted Radiotherapy Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Targeted Radiotherapy Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Targeted Radiotherapy Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Targeted Radiotherapy Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Targeted Radiotherapy Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Targeted Radiotherapy Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Targeted Radiotherapy Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Targeted Radiotherapy Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Targeted Radiotherapy Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Targeted Radiotherapy Drug Revenue (2018-2029) & (USD Million)
Figure 13. Targeted Radiotherapy Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Targeted Radiotherapy Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Targeted Radiotherapy Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Targeted Radiotherapy Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Targeted Radiotherapy Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Targeted Radiotherapy Drug Markets in 2022
Figure 27. United States VS China: Targeted Radiotherapy Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Targeted Radiotherapy Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Targeted Radiotherapy Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Targeted Radiotherapy Drug Market Size Market Share by Type in 2022
Figure 31. Radioactive Iodine Therapeutic Drugs
Figure 32. Radioactive Antibody Therapeutic Drugs
Figure 33. Others
Figure 34. World Targeted Radiotherapy Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Targeted Radiotherapy Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Targeted Radiotherapy Drug Market Size Market Share by Application in 2022
Figure 37. General Hospital
Figure 38. Specialty Hospital
Figure 39. Targeted Radiotherapy Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source